The CORE service improvement programme for mental health crisis resolution teams: results from a cluster-randomised trial.


Journal

The British journal of psychiatry : the journal of mental science
ISSN: 1472-1465
Titre abrégé: Br J Psychiatry
Pays: England
ID NLM: 0342367

Informations de publication

Date de publication:
06 2020
Historique:
pubmed: 15 2 2019
medline: 10 4 2021
entrez: 15 2 2019
Statut: ppublish

Résumé

Crisis resolution teams (CRTs) offer brief, intensive home treatment for people experiencing mental health crisis. CRT implementation is highly variable; positive trial outcomes have not been reproduced in scaled-up CRT care. To evaluate a 1-year programme to improve CRTs' model fidelity in a non-masked, cluster-randomised trial (part of the Crisis team Optimisation and RElapse prevention (CORE) research programme, trial registration number: ISRCTN47185233). Fifteen CRTs in England received an intervention, informed by the US Implementing Evidence-Based Practice project, involving support from a CRT facilitator, online implementation resources and regular team fidelity reviews. Ten control CRTs received no additional support. The primary outcome was patient satisfaction, measured by the Client Satisfaction Questionnaire (CSQ-8), completed by 15 patients per team at CRT discharge (n = 375). Secondary outcomes: CRT model fidelity, continuity of care, staff well-being, in-patient admissions and bed use and CRT readmissions were also evaluated. All CRTs were retained in the trial. Median follow-up CSQ-8 score was 28 in each group: the adjusted average in the intervention group was higher than in the control group by 0.97 (95% CI -1.02 to 2.97) but this was not significant (P = 0.34). There were fewer in-patient admissions, lower in-patient bed use and better staff psychological health in intervention teams. Model fidelity rose in most intervention teams and was significantly higher than in control teams at follow-up. There were no significant effects for other outcomes. The CRT service improvement programme did not achieve its primary aim of improving patient satisfaction. It showed some promise in improving CRT model fidelity and reducing acute in-patient admissions.

Sections du résumé

BACKGROUND
Crisis resolution teams (CRTs) offer brief, intensive home treatment for people experiencing mental health crisis. CRT implementation is highly variable; positive trial outcomes have not been reproduced in scaled-up CRT care.
AIMS
To evaluate a 1-year programme to improve CRTs' model fidelity in a non-masked, cluster-randomised trial (part of the Crisis team Optimisation and RElapse prevention (CORE) research programme, trial registration number: ISRCTN47185233).
METHOD
Fifteen CRTs in England received an intervention, informed by the US Implementing Evidence-Based Practice project, involving support from a CRT facilitator, online implementation resources and regular team fidelity reviews. Ten control CRTs received no additional support. The primary outcome was patient satisfaction, measured by the Client Satisfaction Questionnaire (CSQ-8), completed by 15 patients per team at CRT discharge (n = 375). Secondary outcomes: CRT model fidelity, continuity of care, staff well-being, in-patient admissions and bed use and CRT readmissions were also evaluated.
RESULTS
All CRTs were retained in the trial. Median follow-up CSQ-8 score was 28 in each group: the adjusted average in the intervention group was higher than in the control group by 0.97 (95% CI -1.02 to 2.97) but this was not significant (P = 0.34). There were fewer in-patient admissions, lower in-patient bed use and better staff psychological health in intervention teams. Model fidelity rose in most intervention teams and was significantly higher than in control teams at follow-up. There were no significant effects for other outcomes.
CONCLUSIONS
The CRT service improvement programme did not achieve its primary aim of improving patient satisfaction. It showed some promise in improving CRT model fidelity and reducing acute in-patient admissions.

Identifiants

pubmed: 30761976
pii: S0007125019000217
doi: 10.1192/bjp.2019.21
pmc: PMC7511901
doi:

Banques de données

ISRCTN
['ISRCTN47185233']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

314-322

Subventions

Organisme : Department of Health
ID : RP-PG-0109-10078
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Adm Policy Ment Health. 2012 Sep;39(5):353-64
pubmed: 21574016
BMJ. 2005 Sep 17;331(7517):599
pubmed: 16103032
Psychiatr Serv. 2007 Oct;58(10):1279-84
pubmed: 17914003
Int J Ment Health Nurs. 2018 Feb;27(1):214-226
pubmed: 28075067
J Psychiatr Ment Health Nurs. 2007 May;14(3):310-8
pubmed: 17430455
BMJ. 2012 Sep 04;345:e5661
pubmed: 22951546
Trials. 2016 Mar 22;17:158
pubmed: 27004517
BMC Psychiatry. 2017 Jul 17;17(1):254
pubmed: 28716022
Br J Psychiatry. 2005 Jul;187:68-75
pubmed: 15994574
BMC Psychiatry. 2015 Apr 08;15:74
pubmed: 25879674
Br J Psychiatry. 2011 Jul;199(1):71-6
pubmed: 21292926
J Dual Diagn. 2013 Jan 1;9(2):165-170
pubmed: 24072988
Acta Psychiatr Scand. 2009 Apr;119(4):320-4
pubmed: 19053969
Cochrane Database Syst Rev. 2015 Dec 03;(12):CD001087
pubmed: 26633650
BJPsych Bull. 2018 Aug;42(4):146-151
pubmed: 29792390
PLoS One. 2014 Jul 10;9(7):e100153
pubmed: 25010773
Eval Program Plann. 1982;5(3):233-7
pubmed: 10259963
BMC Psychiatry. 2016 Dec 1;16(1):427
pubmed: 27905909

Auteurs

Brynmor Lloyd-Evans (B)

Senior Lecturer, Division of Psychiatry, University College London, UK.

David Osborn (D)

Professor of Psychiatric Epidemiology, Division of Psychiatry, University College London; and St Pancras Hospital, Camden and Islington NHS Foundation Trust, UK.

Louise Marston (L)

Principal Research Associate, Department of Primary Care and Population Health, UCL Medical School (Royal Free Campus); and Priment Clinical Trials Unit, UK.

Danielle Lamb (D)

Research Associate, Division of Psychiatry, University College London, UK.

Gareth Ambler (G)

Associate Professor in Medical Statistics, Department of Statistical Science, UCL, UK.

Rachael Hunter (R)

Senior Research Associate, Department of Primary Care and Population Health, UCL Medical School (Royal Free Campus); and Priment Clinical Trials Unit, UK.

Oliver Mason (O)

Reader in Clinical Psychology, School of Psychology, University of Surrey, UK.

Sarah Sullivan (S)

Research Fellow, Epidemiology and Health Services Research, CLAHRC West, UK.

Claire Henderson (C)

Clinical Senior Lecturer, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, UK.

Steve Onyett (S)

previously Chief Executive, Onyett Entero, UK.

Elaine Johnston (E)

Principal Research Associate, Division of Psychiatry, University College London, UK.

Nicola Morant (N)

Associate Professor, Division of Psychiatry, University College London, UK.

Fiona Nolan (F)

Professor of Nursing, School of Health and Human Sciences, University of Essex, UK.

Kathleen Kelly (K)

Consultant Psychiatrist, Barnes Unit, John Radcliffe Hospital, Oxford Health NHS Foundation Trust, UK.

Marina Christoforou (M)

Research Assistant, Division of Psychiatry, University College London, UK.

Kate Fullarton (K)

Research Assistant, Division of Psychiatry, University College London, UK.

Rebecca Forsyth (R)

Research Assistant, Division of Psychiatry, University College London, UK.

Mike Davidson (M)

Research Assistant, Division of Psychiatry, University College London, UK.

Jonathan Piotrowski (J)

Research Assistant, Avon and Wiltshire Mental Health Partnership NHS Trust, Research & Development Office, UK.

Edward Mundy (E)

Research Assistant, Division of Psychiatry, University College London, UK.

Gary Bond (G)

Professor of Psychiatry, Westat, Rivermill Commercial Center, UK.

Sonia Johnson (S)

Professor of Social and Community Psychiatry, Division of Psychiatry, University College London; and St Pancras Hospital, Camden and Islington NHS Foundation Trust, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH